Phytopharmacy & Phytomedicine
Phase 3 — Phytochemical Screening & Characterization
3.7 Chapter Summary
Common Interview and Viva Questions

Common Interview and Viva Questions

Name the reagent and expected colour change for the preliminary detection of alkaloids, flavonoids, and saponins.Explain the biosynthetic difference between...

Phytopharmacy & PhytomedicinePhase 3 — Phytochemical Screening & Characterization3.7 Chapter Summary1 min readUpdated 2026-07-11
  • Name the reagent and expected colour change for the preliminary detection of alkaloids, flavonoids, and saponins.
  • Explain the biosynthetic difference between a mevalonate-pathway and non-mevalonate (MEP)-pathway terpenoid.
  • What information does HMBC provide that HSQC cannot?
  • Why is a neutral loss of 162 Da diagnostic in the mass spectrum of a glycoside?
  • Differentiate an 'active marker' from an 'analytical marker' compound.
  • Outline the steps of bioassay-guided fractionation.

Related Topics